Colin Marchant, MD, is an Associate Professor of pediatrics at the Boston University School of Medicine. After serving as chief resident in Pediatrics at the Cleveland Metropolitan General Hospital in Cleveland, he joined the school of medicine as an Adjunct Associate Professor. He has written chapters, articles, and reviews on infectious disease in children, his main research interest.
- Active Staff Privileges, Infectious Diseases, Pediatrics, Boston Medical Center
- McGill University, MD
- Acadia University, BSc
- Published on 10/28/2017
Stockwell MS, Marchant CD, Wodi AP, Barnett ED, Broder KR, Jakob K, Lewis P, Kattan M, Rezendes AM, Barrett A, Sharma D, Fernandez N, LaRussa P. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging. Vaccine. 2017 12 15; 35(50):6941-6948. PMID: 29089191.
- Published on 5/1/2014
Loughlin AM, Hsu K, Silverio AL, Marchant CD, Pelton SI. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J. 2014 May; 33(5):504-10. PMID: 24670957.
- Published on 6/1/2013
Marshall GS, Blatter M, Marchant C, Aris E, Mesaros N, Miller JM. Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age. Pediatr Infect Dis J. 2013 Jun; 32(6):662-8. PMID: 23340564.
- Published on 2/26/2013
Williams SE, Edwards KM, Baxter RP, LaRussa PS, Halsey NA, Dekker CL, Vellozzi C, Marchant CD, Donofrio PD, Reimschisel TE, Berger M, Gidudu JF, Klein NP. Comprehensive assessment of serious adverse events following immunization by health care providers. J Pediatr. 2013 Jun; 162(6):1276-81, 1281.e1. PMID: 23452584.
- Published on 2/1/2013
Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM. Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination. Pediatr Infect Dis J. 2013 Feb; 32(2):163-8. PMID: 23334340.
- Published on 10/9/2012
Loughlin AM, Marchant CD, Adams W, Barnett E, Baxter R, Black S, Casey C, Dekker C, Edwards KM, Klein J, Klein NP, LaRussa P, Sparks R, Jakob K. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2012 Nov 26; 30(50):7253-9. PMID: 23063829.
- Published on 8/1/2012
Bryant K, McVernon J, Marchant C, Nolan T, Marshall G, Richmond P, Marshall H, Nissen M, Lambert S, Aris E, Mesaros N, Miller J. Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in toddlers: a pooled analysis of randomized trials. Hum Vaccin Immunother. 2012 Aug; 8(8):1036-41. PMID: 22617844.
- Published on 7/24/2012
Rowhani-Rahbar A, Klein NP, Dekker CL, Edwards KM, Marchant CD, Vellozzi C, Fireman B, Sejvar JJ, Halsey NA, Baxter R. Biologically plausible and evidence-based risk intervals in immunization safety research. Vaccine. 2012 Dec 17; 31(1):271-7. PMID: 22835735.
- Published on 4/14/2012
Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, Larussa P, Marchant C, Slade B, Vellozzi C. Algorithm to assess causality after individual adverse events following immunizations. Vaccine. 2012 Aug 24; 30(39):5791-8. PMID: 22507656.
- Published on 3/19/2012
Cherry JD, Tan T, Wirsing von König CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012 Jun; 54(12):1756-64. PMID: 22431797.
View 62 more publications: View full profile at BUMC